Journal Article

Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings

Tabori, Harold, Mentzel, Hans-Joachim, Gerber, Andrea, Mainz, Jochen G., Jaudszus, Anke, Lorenz, Michael, Reinsch, Steffen, Lehmann, Thomas, Arnold, Christin, Michl, Ruth, Renz, Diane M.

2017

Overview

Abdominal symptoms (AS) are a hallmark of the multiorgan-disease cystic fibrosis (CF). However, the abdominal involvement in CF is insufficiently understood and, compared to the pulmonary manifestation, still receives little scientific attention. Aims were to assess and quantify AS and to relate them to laboratory parameters, clinical findings, and medical history. A total of 131 patients with CF of all ages were assessed with a new CF-specific questionnaire (JenAbdomen-CF score 1.0) on abdominal pain and non-pain symptoms, disorders of appetite, eating, and bowel movements as well as symptom-related quality of life. Results were metrically dimensioned and related to abdominal manifestations, history of surgery, P. aeruginosa and S. aureus colonization, genotype, liver enzymes, antibiotic therapy, lung function, and nutritional status. AS during the preceding 3 months were reported by all of our patients. Most common were lack of appetite (130/131) and loss of taste (119/131) followed by abdominal pain (104/131), flatulence (102/131), and distention (83/131). Significantly increased AS were found in patients with history of rectal prolapse (p = 0.013), distal intestinal obstruction syndrome (p = 0.013), laparotomy (p = 0.022), meconium ileus (p = 0.037), pancreas insufficiency (p = 0.042), or small bowel resection (p = 0.048) as well as in patients who have been intermittently colonized with P. aeruginosa (p = 0.006) compared to patients without history of these events. In contrast, no statistically significant associations were found to CF-associated liver disease, chronic pathogen colonization, lung function, CF-related diabetes, and nutritional status. As the complex abdominal involvement in CF is still not fully understood, the assessment of the common AS is of major interest. In this regard, symptom questionnaires like the herein presented are meaningful and practical tools facilitating a wider understanding of the abdominal symptoms in CF. Furthermore, they render to evaluate possible abdominal effects of novel modulators of the underlying cystic fibrosis transmembrane (conductance) regulator (CFTR) defect.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Abdomen / Abdomen - physiopathology / Adolescent / Age / Antibiotics / Appetite loss / Biology and Life Sciences / Child / Child, Preschool / Colonization / Conductance / Cystic fibrosis / Cystic Fibrosis - genetics / Cystic Fibrosis - pathology / Cystic Fibrosis - physiopathology / Cystic Fibrosis Transmembrane Conductance Regulator - genetics / Diabetes mellitus / Disorders / Enzymes / Female / Gastroesophageal reflux / Genetic aspects / Genotype / Genotypes / Hospitals / Humans / Infant / Infant, Newborn / Inflammation / Laboratories / Liver / Liver diseases / Lung diseases / Lungs / Male / Meconium / Medicine and Health Sciences / Modulators / Mutation / Nutritional status / Pain / Pancreas / Patients / Pediatrics / Quality of life / Questionnaires / Rectum / Research and Analysis Methods / Respiratory function / Signs and symptoms / Small intestine / Statistical analysis / Studies / Surgery